Australia markets open in 52 minutes

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.21-0.55 (-2.22%)
At close: 04:00PM EDT
24.00 -0.21 (-0.87%)
After hours: 05:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.17B
Enterprise value 1.17B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.77
Price/book (mrq)4.97
Enterprise value/revenue 5.23
Enterprise value/EBITDA -5.66

Trading information

Stock price history

Beta (5Y monthly) 1.13
52-week change 3-5.60%
S&P500 52-week change 326.94%
52-week high 335.56
52-week low 323.14
50-day moving average 325.20
200-day moving average 328.04

Share statistics

Avg vol (3-month) 3481.47k
Avg vol (10-day) 3402.95k
Shares outstanding 547.13M
Implied shares outstanding 647.13M
Float 835.37M
% held by insiders 12.23%
% held by institutions 1118.50%
Shares short (15 May 2024) 48.81M
Short ratio (15 May 2024) 421.95
Short % of float (15 May 2024) 421.78%
Short % of shares outstanding (15 May 2024) 418.70%
Shares short (prior month 15 Apr 2024) 48.58M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -70.79%
Operating margin (ttm)-38.24%

Management effectiveness

Return on assets (ttm)-13.76%
Return on equity (ttm)-84.40%

Income statement

Revenue (ttm)224M
Revenue per share (ttm)5.18
Quarterly revenue growth (yoy)119.10%
Gross profit (ttm)N/A
EBITDA -93.32M
Net income avi to common (ttm)-158.56M
Diluted EPS (ttm)-3.74
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)302.84M
Total cash per share (mrq)6.43
Total debt (mrq)307.52M
Total debt/equity (mrq)131.08%
Current ratio (mrq)3.68
Book value per share (mrq)4.99

Cash flow statement

Operating cash flow (ttm)-36.96M
Levered free cash flow (ttm)-15.42M